HHS has published a subset of its semiannual rulemaking agenda for 2023, outlining those planned rules – including several from the FDA – that are likely to have a significant economic impact for some small entities.
Source: Drug Industry Daily
HHS Lists Planned FDA Rules Likely to Have Significant Economic Impacts
- Post author:PacConAdmin
- Post published:February 22, 2023
- Post category:Drug Industry Daily